Загрузка...
Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
Background: Tamoxifen, as a treatment of estrogen receptor positive (ER+) breast cancer, is a weak anti-estrogen that requires metabolic activation to form metabolites with higher anti-estrogenic activity. Endoxifen is the most-studied active tamoxifen metabolite, and endoxifen concentrations are hi...
Сохранить в:
| Опубликовано в: : | J Pers Med |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8228634/ https://ncbi.nlm.nih.gov/pubmed/34199712 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060507 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|